Patents Assigned to CEBINA GMBH
  • Antiviral treatment
    Patent number: 11433080
    Abstract: A method of treating a subject in need of anti-coronavirus treatment by providing a prophylactic or therapeutic treatment which includes an antiviral effective amount of an Azelastine compound, where the antiviral effective amount is 0.1-500 ?g per dose. An Azelastine compound can also be used as an antiviral substance in a medicinal product for treating a biological surface to prevent coronavirus infection and/or coronavirus spread, or as a viral disinfectant.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: September 6, 2022
    Assignee: CEBINA GMBH
    Inventors: Eszter Nagy, Gabor Nagy, Valeria Szijarto, Robert Konrat
  • Antiviral treatment
    Patent number: 11273163
    Abstract: A method of treating a subject in need of anti-Coronavirus treatment comprising prophylactic or therapeutic treatment, with an antiviral effective amount of an Azelastine compound, wherein the antiviral effective amount is 0.1-500 ?g per dose; use of an Azelastine compound as an antiviral substance in a medicinal product for treating a biological surface to prevent from Coronavirus infection and/or Coronavirus spread, and use of an Azelastine compound as viral disinfectant.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: March 15, 2022
    Assignee: CEBINA GMBH
    Inventors: Eszter Nagy, Gabor Nagy, Valeria Szijarto, Robert Konrat